In contrast, deletion of HIF-1α in TCRP1A CD8 T cells showed attenuated anti-tumor activity, confirming the pivotal role of HIF-1α signaling in the modulation of CD8 T-cell responses against tumors. This evidence concerns the gene CD8A and neoplasm.